Inhibition of neural activity depletes orexin from rat hypothalamic slice culture

Journal of Neuroscience Research

Volumn 88, Issue 1, 2010, Pages 214-221

  Michinaga, Shotaro ^a   Hisatsune, Akinori ^a   Isohama, Yoichiro ^a   Katsuki, Hiroshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Calcium; Hypocretin; Neuropeptides

Indexed keywords

CALCIUM ION; GLUTAMIC ACID; MAGNESIUM CHLORIDE; MAGNESIUM ION; MELANIN CONCENTRATING HORMONE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OREXIN; TETRODOTOXIN; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; HYPOTHALAMUS; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; TISSUE CULTURE;

ANALYSIS OF VARIANCE; ANIMALS; CALCIUM; CALCIUM CHANNELS; CELL COUNT; CELL DEATH; FLUORESCENT ANTIBODY TECHNIQUE; HYPOTHALAMIC HORMONES; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANINS; N-METHYLASPARTATE; NEURAL INHIBITION; NEURONS; NEUROPEPTIDES; ORGAN CULTURE TECHNIQUES; PITUITARY HORMONES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNAPTIC TRANSMISSION; TETRODOTOXIN; TIME FACTORS;

EID: 73949160789     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22183     Document Type: Article

References (30)

1. Abe K. 2008. Neural activity-dependent regulation of gene expression in developing and mature neurons. Dev Growth Differ 50:261-271.
2. Acuna-Goycolea C, Li Y, van den Pol AN. 2004. Group III metabotropic glutamate receptors maintain tonic inhibition of excitatory synaptic input to hypocretin/orexin neurons. J Neurosci 24:3013-3022.
3. Baker RE, Ruijter JM, Bingmann D. 1991. Effect of chronic exposure to high magnesium on neuron survival in long-term neocortical explants of neonatal rats in vitro. Int J Dev Neurosci 9:597-606.
4. Brana C, Benham C, Sundstrom L. 2002. A method for characterising cell death in vitro by combining propidium iodide staining with immunohistochemistry. Brain Res Protoc 10:109-114.
5. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-451.
6. Chen Y, Ghosh A. 2005. Regulation of dendritic development by neuronal activity. J Neurobiol 64:4-10.
7. Eggermann E, Bayer L, Serafin M, Saint-Mleux B, Bernheim L, Machard D, Jones BE, Muhlethaler M. 2003. The wake-promoting hypocretin-orexin neurons are in an intrinsic state of membrane depolarization. J Neurosci 23:1557-1562.
8. 2+ channels-integration centers for neuronal signaling pathways. Trends Neurosci 29:617-624.
9. Fronczek R, Overeem S, Lee SY, Hegeman IM, van Pelt J, van Duinen SG, Lammers GJ, Swaab DF. 2007. Hypocretin (orexin) loss in Parkinson's disease. Brain 130:1577-1585.
10. Greer PL, Greenberg ME. 2008. From synapse to nucleus: calcium-dependent gene trsanscription in the control of synapse development and function. Neuron 59:846-860.
11. Hassani OK, Lee MG, Jones BE. 2009. Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle. Proc Natl Acad Sci USA 106:2418-2422.
12. Heidenreich KA, Linseman DA. 2004. Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival. Mol Neurobiol 29:155-166.
13. Kato H, Hosoda H, Fukuda T, Masushige S, Kida S. 2007. Characterization of the promoter of the mouse preproorexin gene. Biosci Biotechnol Biochem 71:840-843.
14. Katsuki H, Akaike A. 2004. Excitotoxic degeneration of hypothalamic orexin neurons in slice culture. Neurobiol Dis 15:61-69.
15. Katsuki H, Akaike A. 2005. Quinolinic acid toxicity on orexin neurons blocked by gamma aminobutyric acid type A receptor stimulation. Neuroreport 16:1157-1161.
16. Katsuki H, Takenaka C, Kume T, Kaneko S, Akaike A. 2001. Requirement of neural activity for the maintenance of dopaminergic neurons in rat midbrain slice cultures. Neurosci Lett 300:166-170.
17. Katsuki H, Shibata H, Takenaka C, Kume T, Kaneko S, Akaike A. 2003. N-methyl-D-aspartate receptors contribute to the maintenance of dopaminergic neurons in rat midbrain slice cultures. Neurosci Lett 341:123-126.
18. Kilduff TS, Peyron C. 2000. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 23:359-365.
19. Lee MG, Hassani OK, Jones BE. 2005. Discharge of indentified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 25:6716-6720.
20. Li Y, Gao XB, Sakurai T, van den Pol AN. 2002. Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron - a potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36:1169-1181.
21. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiun X, de Jong PJ, Nishino S, Mignot E. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-376.
22. Mileykovskiy BY, Kiyashchenko LI, Siegel JM. 2005. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46:787-798.
23. Perez-Reyes E. 2003. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83:117-161.
24. Petersén A, Gil J, Maat-Schieman ML, Björkqvist M, Tanila H, Araújo IM, Smith R, Popovic N, Wierup N, Norlén P, Li JY, Roos RA, Sundler F, Mulder H, Brundin P. 2005. Orexin loss in Huntington's disease. Hum Mol Genet 14:39-47.
25. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Hungs RLM, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E. 2000. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991-997.
26. Sakurai T. 2007. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8:171-181.
27. Scammell TE. 2003. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 53:154-166.
28. Takahashi T. 1990. Membrane currents in visually identified motoneurones of neonatal rat spinal cord. J Physiol 423:27-46.
29. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Sulyani S, Aldrich M, Cornford M, Siegel JM. 2000. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469-474.
30. Thannickal TC, Lai YY, Siegel JM. 2007. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 130:1586-1595.